David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
PUT
Accenture
ACN
$111B
| $974K | ﹤0.01% |
10,400
-68,600
| -87% | -$6.12M |
|
2552
CALL
Archer Daniels Midland
ADM
$38.6B
| $967K | ﹤0.01% |
20,400
-20,000
| -50% | -$952K |
|
2553
Avient
AVNT
$4.11B
| $967K | ﹤0.01% |
25,886
-17,154
| -40% | -$651K |
|
2554
Century Aluminum
CENX
$4.35B
| $966K | ﹤0.01% |
+70,000
| New | +$1.41M |
|
2555
PUT
MasTec
MTZ
$20B
| $965K | ﹤0.01% |
50,000
-27,900
| -36% | -$558K |
|
|
FRSH
2556
DELISTED
Papa Murphy's Holdings, Inc
FRSH
| $964K | ﹤0.01% |
53,143
+5,903
| +12% | +$81K |
|
2557
California Water Service
CWT
$3.11B
| $963K | ﹤0.01% |
39,303
-14,813
| -27% | -$366K |
|
|
POZN
2558
DELISTED
POZEN INC
POZN
| $963K | ﹤0.01% |
124,793
+24,715
| +25% | +$180K |
|
2559
Acacia Research
ACTG
$438M
| $962K | ﹤0.01% |
89,827
+69,671
| +346% | +$909K |
|
|
SEM
2560
DELISTED
Select Medical
SEM
| $962K | ﹤0.01% |
120,365
-885,652
| -88% | -$6.62M |
|
2561
Acadia Pharmaceuticals
ACAD
$5.1B
| $960K | ﹤0.01% |
29,449
-144,752
| -83% | -$4.98M |
|
2562
Q2 Holdings
QTWO
$4.05B
| $959K | ﹤0.01% |
45,343
+15,814
| +54% | +$312K |
|
|
TCF
2563
DELISTED
TCF Financial Corporation Common Stock
TCF
| $957K | ﹤0.01% |
30,521
-17,351
| -36% | -$520K |
|
2564
New Mountain Finance
NMFC
$715M
| $956K | ﹤0.01% |
65,477
+45,611
| +230% | +$669K |
|
|
BT
2565
DELISTED
BT Group plc (ADR)
BT
| $954K | ﹤0.01% |
+29,292
| New | +$966K |
|
2566
LXP Industrial Trust
LXP
$3.6B
| $951K | ﹤0.01% |
+19,355
| New | +$1.05M |
|
2567
Travere Therapeutics
TVTX
$6.33B
| $951K | ﹤0.01% |
39,700
-5,900
| -13% | -$90K |
|
2568
Wayfair
W
$14.2B
| $951K | ﹤0.01% |
29,601
-19,729
| -40% | -$490K |
|
2569
TG Therapeutics
TGTX
$8.42B
| $950K | ﹤0.01% |
+61,346
| New | +$929K |
|
|
RGC
2570
DELISTED
Regal Entertainment Group
RGC
| $950K | ﹤0.01% |
41,605
-67,546
| -62% | -$1.5M |
|
|
HSNI
2571
DELISTED
HSN, Inc.
HSNI
| $950K | ﹤0.01% |
13,920
+1,779
| +15% | +$125K |
|
2572
CALL
CSX Corp
CSX
$95.9B
| $947K | ﹤0.01% |
85,800
-46,200
| -35% | -$531K |
|
2573
Philips
PHG
$26.4B
| $946K | ﹤0.01% |
48,174
+2,910
| +6% | +$58K |
|
2574
CALL
Agios Pharmaceuticals
AGIO
$2.03B
| $943K | ﹤0.01% |
10,000
| – | – |
|
|
2575
PUT
Agios Pharmaceuticals
AGIO
$2.03B
| $943K | ﹤0.01% |
10,000
| – | – |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $2.47B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.